Fibiger Hans Christian 4
4 · Valeant Pharmaceuticals International, Inc. · Filed Oct 6, 2010
Insider Transaction Report
Form 4
Fibiger Hans Christian
Chief Scientific Officer
Transactions
- Award
Restricted Share Units
2010-10-04+52→ 14,416 totalFrom: 2011-11-24Exp: 2011-11-24→ Common Stock, no par value (52 underlying) - Award
Restricted Share Units
2010-10-04+187→ 51,329 totalFrom: 2014-08-05Exp: 2014-08-05→ Common Stock, no par value (187 underlying)
Footnotes (2)
- [F1]Each Restricted Share Unit represents a contingent right to receive one share of Common Stock, no par value, of Valeant Pharmaceuticals International, Inc. (the "Common Stock").
- [F2]Represents dividend equivalents accrued on Restricted Share Units as a result of a dividend paid on the Common Stock on October 4, 2010.